Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

Also known as: FLT3-Mutated Acute Myeloid Leukemia / FLT3 mutated AML

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab1 / 2Completed1
DB00928Azacitidine1 / 2Recruiting1
DB00928Azacitidine1 / 2Withdrawn1
DB00987Cytarabine1 / 2Active Not Recruiting1
DB12141Gilteritinib1 / 2Active Not Recruiting1
DB12141Gilteritinib1 / 2Completed1
DB12141Gilteritinib1 / 2Recruiting1
DB01177Idarubicin1 / 2Active Not Recruiting1
DB06300Ponatinib1 / 2Withdrawn1
DB08901Ponatinib1 / 2Withdrawn1
DB11581Venetoclax1 / 2Recruiting1
DB00987Cytarabine2Recruiting1
DB00694Daunorubicin2Recruiting1
DB00773Etoposide2Recruiting1
DB01073Fludarabine2Recruiting1
DB01177Idarubicin2Recruiting1
DB06595Midostaurin2Recruiting1
DB01204Mitoxantrone2Recruiting1
DB00928Azacitidine3Active Not Recruiting1
DB00987Cytarabine3Active Not Recruiting1
DB00773Etoposide3Active Not Recruiting1
DB00099Filgrastim3Active Not Recruiting1
DB01073Fludarabine3Active Not Recruiting1
DB12141Gilteritinib3Active Not Recruiting2
DB01204Mitoxantrone3Active Not Recruiting1
DB12141GilteritinibNot AvailableRecruiting1
DB06595MidostaurinNot AvailableNo Longer Available1